Home / News / India News / Article /
Bharat Biotech's COVID-19 vaccine 'Covaxin' commences phase-3 trial
Updated On: 27 November, 2020 10:24 AM IST | New Delhi | IANS
M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received the first dose of Covaxin. Around 15,000 volunteers at AIIMS will be given the shot as part of the clinical trials
Listen to this article :
Representation pic
The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday.
M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received the first dose of Covaxin. Around 15,000 volunteers at AIIMS will be given the shot as part of the clinical trials.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT